Oxamniquine

CAS No. 21738-42-1

Oxamniquine ( —— )

Catalog No. M21872 CAS No. 21738-42-1

Oxamniquine is a potent agent for the treatment of schistosomiasis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 1143 Get Quote
50MG 2322 Get Quote
100MG 3060 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Oxamniquine
  • Note
    Research use only, not for human use.
  • Brief Description
    Oxamniquine is a potent agent for the treatment of schistosomiasis.
  • Description
    Oxamniquine is a potent agent for the treatment of schistosomiasis.
  • In Vitro
    Oxamniquine is a potent agent for the treatment of schistosomiasis.
  • In Vivo
    Oxamniquine (500 mg/kg) alone or Oxamniquine (250 mg/kg) in combination with praziquantel reduces the mortality of infected snails compared to the control group.
  • Synonyms
    ——
  • Pathway
    Microbiology/Virology
  • Target
    Parasite
  • Recptor
    Parasite
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    21738-42-1
  • Formula Weight
    279.33
  • Molecular Formula
    C??H??N?O?
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    OCC1=C([N+]([O-])=O)C=C2C(CCC(CNC(C)C)N2)=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Mattos AC, et al. Evaluation of the effect of oxamniquine, praziquantel and a combination of both drugs on the intramolluscan phase of Schistosoma mansoni. Acta Trop. 2007 May;102(2):84-91.
molnova catalog
related products
  • AP-C5

    AP-C5 is a compound with selective inhibition of guanosine 3',5' cyclic monophosphate (cGMP)-dependent protein kinase II (cGKII), with a Pic50 value of 7.2 for cGMP, and can be used in the study of diarrheal diseases.

  • PK 11195

    PK 11195 (RP 52028) is a TSPO ligand for neuroimaging that exhibits significant protection against CoCl2-induced alterations and can be used to study leishmaniasis.

  • SCYX-7158

    SCYX-7158 (AN-5568, Acoziborole) is an orally-active, CNS permeable benzoxaborole antiprotozoal agent.